2025-12-06 - Analysis Report
Here's an analysis of Northrop Grumman (NOC) based on the provided data:

**1) Return Rate Comparison and Alpha/Beta Analysis**

*   **Company Overview:** Northrop Grumman Corp is an aerospace and defense technology company.
*   **Return Performance:**
    *   NOC Cumulative Return: 43.57%
    *   VOO Cumulative Return: 100.58%
    *   Divergence: -53.7 (NOC underperformed VOO)
    *   Relative Divergence: 3.1 (near the lowest point of historical divergence)
*   **Analysis of Alpha/Beta:**

| Year       | CAGR  | MDD   | Alpha  | Beta | Cap(B) |
| :---------- | :---- | :---- | :----- | :--- | :------ |
| 2015-2017  | 46.0% | 65.6% | 17.0%  | 0.0  | 43.6   |
| 2016-2018  | -2.0% | 74.3% | -17.0% | 0.0  | 34.8   |
| 2017-2019  | 17.0% | 79.2% | -5.0%  | 0.9  | 48.9   |
| 2018-2020  | -28.0% | 79.9% | -52.0% | 0.8  | 43.3   |
| 2019-2021  | 43.0% | 79.9% | -4.0%  | 0.8  | 55.0   |
| 2020-2022  | 18.0% | 79.9% | 19.0%  | 0.3  | 77.5   |
| 2021-2023  | 24.0% | 82.7% | 23.0%  | 0.2  | 66.5   |
| 2022-2024  | -15.0% | 82.7% | -36.0% | 0.2  | 66.7   |
| 2023-2025  | -7.0%  | 82.1% | -72.0% | 0.1  | 78.6   |

*   **CAGR and MDD:** The CAGR (Compound Annual Growth Rate) has fluctuated significantly, showing periods of strong growth and declines. The MDD (Maximum Drawdown) is consistently high, indicating significant potential losses.
*   **Alpha:** Alpha, representing the excess return relative to the benchmark, is negative in several periods, particularly the recent years (2018-2020, 2022-2025). This suggests underperformance compared to market expectations.
*   **Beta:** Beta is generally low (close to zero in 2015-2018 and decreasing from 0.9 to 0.1 in recent years), implying lower volatility than the market and lower sensitivity to market movements.
*   **Capitalization:** The company's capitalization (Cap) has generally increased over time, suggesting overall growth in size.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 553.32
*   **Last Market Data:** Price: 548.81, Previous Close: 553.0, Change: -0.76 (a slight decrease)
*   **Moving Averages:**
    *   5-day SMA: 557.98
    *   20-day SMA: 563.45
    *   60-day SMA: 584.95
*   **Analysis:** The stock price is below all three moving averages (5-day, 20-day, and 60-day), indicating a potential downward trend.

**3) RSI, PPO, and Expected Return Analysis**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 45.41 (Neutral - not overbought or oversold)
*   **PPO:** -0.0665 (Slightly negative, suggesting a potential short-term bearish trend.)
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Dividend_2.31 Monthly invest 0.8% of total investment ($1,000.00)" - This signal suggests a buy recommendation with a focus on dividends, potentially a defensive strategy.
*   **Recent Relative Divergence Change:** -6.8 (Indicates a short-term downward trend)
*   **Expected Return:** -212.7% (Very negative, suggesting significant underperformance compared to S&P 500 if held long-term. This is highly unusual and potentially an error in the calculation.)

**4) Recent News & Significant Events**

*   **Negative Headlines:** Multiple articles highlight concerns, including a "Sell" recommendation and Lumbard & Kellner LLC reducing holdings.
*   **Dividend Declaration:** The company declared a quarterly dividend of $2.31 per share, which is positive news for income-seeking investors.
*   **Valuation Check:** An article discusses a valuation check after new European defense deals and global demand outlook.
*   **Dow Outperformance:** One article explores whether Northrop Grumman is outperforming the Dow.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.09)
*   **Target Price:** Average: 663.21, High: 770.00, Low: 533.00
*   **Analysis:** Analysts generally have a positive outlook with a "Buy" consensus and a significant average target price above the current price. However, the low target price is below the current price, indicating a range of opinions.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출        |
| :--------- | :--- | :---------- |
| 2025-10-21 | 7.69 | 10.42 B$    |
| 2025-07-22 | 8.17 | 10.35 B$    |
| 2025-04-22 | 3.33 | 9.47 B$     |
| 2024-10-24 | 7.02 | 10.00 B$    |
| 2025-10-21 | 7.02 | 10.00 B$    |

*   **Trend:** Revenue has shown some volatility, with a recent increase. EPS (Earnings Per Share) also shows variability.
*   **Note:** There is a duplicate entry for "2025-10-21" which needs to be corrected for an accurate analysis.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-09-30   | $10.42B  | 21.37%        |
| 2025-06-30   | $10.35B  | 21.35%        |
| 2025-03-31   | $9.47B   | 16.69%        |
| 2024-12-31   | $10.69B  | 18.08%        |
| 2024-09-30   | $10.00B  | 21.07%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
| :----------- | :-------- | :---- |
| 2025-09-30   | $15.99B  | 6.88% |
| 2025-06-30   | $15.47B  | 7.59% |
| 2025-03-31   | $14.98B  | 3.21% |
| 2024-12-31   | $15.29B  | 8.27% |
| 2024-09-30   | $14.75B  | 6.96% |

*   **Revenue:** Revenue has been relatively stable, with a slight increase in the most recent quarter.
*   **Profit Margin:** The profit margin is generally high, indicating strong profitability.
*   **Equity:** Equity has been increasing, reflecting a growing balance sheet.
*   **ROE:** Return on Equity (ROE) has fluctuated but is generally positive, indicating profitability relative to shareholder equity.

**7) Comprehensive Analysis**

*   **Mixed Signals:** NOC presents a mixed bag of indicators.
*   **Underperformance:**  The stock has significantly underperformed the S&P 500 over the period covered. The relative divergence is near its lowest point, suggesting the underperformance might be at an extreme.
*   **Technicals:** The stock is trading below its moving averages, suggesting a short-term downtrend.
*   **Analyst Sentiment:** Analyst ratings are generally positive ("Buy"), and target prices are higher than the current price.
*   **Financials:** NOC has strong revenues, profit margins, and a growing equity base.
*   **News:** Recent news articles are mixed, with both positive and negative headlines.
*   **Risk:** MRI is medium (0.8).
*   **Concerns:** The excessively negative expected return needs to be verified. The high MDD values indicate significant potential downsides.
*   **Overall:** The current picture of NOC suggests caution. While analyst ratings and financials are relatively strong, the stock's underperformance, technical indicators, and negative news warrant a careful consideration of risk tolerance before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.